In vitro chemosensitivity of human pancreatic cancer cell lines

International Journal of Pancreatology

Volumn 20, Issue 3, 1996, Pages 185-190

  Sawabe, Yasunori ^a   Yamagishi, Hisakazu ^a   Yamaguchi, Nozomi ^a   Yamamura, Yoshiro ^a   Oka, Takahiro ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

alamar blue assay; growth inhibition curve; human pancreatic cancer cell line; in vitro chemosensitivity; Pancreatic cancer

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MITOMYCIN C;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER REGRESSION; DRUG EFFICACY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL;

EID: 0030472461     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02803767     Document Type: Article

References (26)

1. Tashiro S, Uchino R, Hiraoka T, Tsuji T, Kawamoto S, Saitoh N, Yamasaki K, Miyauchi Y. Surgical indication and significance of portal vein resection in biliary and pancreatic cancer. Surgery 1991; 109: 481-487.
2. Zerbi A, Fossati V, Parolini D, Carlucci M, Balzano G, Bordogna G, Staudacher C, Di Carlo V. Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer 1994; 73: 2930-2935.
3. Coia L, Hoffman J, Scher R, Weese J, Solin L, Weiner L, Eisenberg B, Paul A, Hanks G. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. Int J Radiat Oncol Biol Phys 1994; 30: 161-167.
4. Kato H, Wakasugi H, Yokota M, Furukawa M, Mukuta T, Yamada Y, Funakoshi A. Effectiveness of chemotherapy for advanced adenocarcinoma of pancreas in combined modality therapy. Int Med 1994; 33: 142-146.
5. Topham C, Gless J, Rawson NSB, Woods EM, Coombes RC. Randomized trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas. Br J Cancer 1991; 64: 179-181.
6. Kelsen D. The use of chemotherapy in the treatment of gastric and pancreas cancer. Semin-Oncol 1994; 21: 58-66.
7. Palmer KR, Kerr M, Knowles G, Cull A, Carter DC, Leonard RC. Chemotherapy prolongs survival in inoperable pancreatic cancer. Br J Surg 1994; 81: 882-885.
8. The gastrointestinal tumor study group. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. J Clin Oncol 1986; 4: 1794-1798.
9. Buchler M, Friess H, Schultheiss KH, Gebhardt C, Kubel R, Muhrer KH, Winkelmann M, Wagener T, Klapdor R, Kaul M. A randomized controlled trial of adjuvant immunotherapy (marine monoclonal antibody 494/32) in resectable pancreatic cancer. Cancer 1991; 68: 1507-1512.
10. Yamaguchi N, Yamamura Y, Koyama K, Ohtsuji E, Imanishi J, Ashihara T. Characterization of new human pancreatic cancercell lines which propagate in aprotein- free chemically defined medium. Cancer Res 1990; 50: 7008-7014.
11. Nio Y, Imai S, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Tobe T. Chemosensitivity correlation between the primary tumors and simultaneous metastatic lymph nodes of patients evaluated by DNA synthesis inhibition assay. Cancer 1990; 65: 1273-1278.
12. 3H]thymidine incorporation assay. J Immunol Methods 1994; 170: 211-224.
13. Werner S, Gary MC, Sydney ES, Scheithauer W, Clark GM, Salmon SE, Dorda W, Shoemaker RH, Von Hoff DD. Model for estimation of clinically achievable plasma concentrations for investigational anticancer drugs in man. Cancer Treat Rep 1986; 70: 1379-1382.
14. Kikuchi Y. Study of in vitro cancer sensitivity of anticancer drugs by SDI (succinate dehydrogenase inhibition) test. Jpn J Cancer Chemother 1994; 21: 2757-2762 (in Japanese with English summary).
15. Arbuck SG. Overview of chemotherapy for pancreatic cancer. Int J Pancreatol 1990; 7: 209-222.
16. Warshaw AL, Castillo CF. Pancreatic carcinoma. N Engl J Med 1992; 326: 455-465.
17. Tanigawa N, Morimoto H, Dohmae N, Shimomatsuya T, Takahashi K, Muraoka R. In vitro growth ability and chemosensitivity of gastric and colorectal cancer cells assessed with the human tumor clonogenic assay and the thymidine incorporation assay. Eur J Cancer 1992; 28: 31-34.
18. Maehara Y, Kohnoe S, Sugimachi K. Chemosensitivity test for carcinoma of digestive organs. Semin Surg Oncol 1990; 6: 42-47.
19. Park JG, Kramer BS, Steinberg SM, Carmichael J, Collins JM, Minna JD, Gazdar AF. Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based calorimetric assay. Cancer Res 1987; 47: 5875-5879.
20. Carmichael J, Mitchell JB, DeGraff WG, Gamson J, Gazdar AF, Johnson BE, Glatstein E, Minna JD. Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer 1985; 57: 540-547.
21. Matsuno S, Hirotake H, Kobari M, Akaishi S. Growth-inhibitory effects of combination chemotherapy for human pancreatic cancer cell lines. Cancer 1990; 66: 2369-2374.
22. Hida T, Ueda R, Takahashi T, Watanabe H, Kato T, Suyama M, Sugiura T, Ariyoshi Y, Takahashi T. Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 12 bromide (MTT) hybrid assay. Cancer Res 1989; 49: 4785-4790.
23. Mitsuhashi Y, Inaba M, Sugiyama Y, Kobayashi T. In vitro measurement of chemosensitivity of human small cell lung and gastric cancer cell lines toward cell cycle phase-nonspecific agents under the clinically equivalent area under the curve. Cancer 1992; 70: 2540-2546.
24. Akiyama S, Amo H, Watanabe T, Matsuyama M, Sakamoto J, Imaizumi M, Ichihashi H, Kondo T, Takagi H. Characteristics of three human gastric cancer cell lines, NU-GC-2, NU-GC-3 and NU-GC-4. Jpn Surg 1988; 18: 438-446.
25. Kondo T. Problems in chemosensitivity testing. Jpn J Cancer Chemother 1995; 22: 592-598 (in Japanese with English summary).
26. Ohigashi H, Ishikawa O, Imaoka S, Sasaki Y, Kabuto T, Kameyama M, Furukawa H, Hiratuka M, Nakamori S, Nakano H, Yasuda T, Iwanaga T. A new method of intra arterial regional chemotherapy with more selective drug delivery for locally advanced pancreatic cancer. Hepato-Gastroenterol 1996; 43: 338-345.